ID   CCC-5
AC   CVCL_LM83
SY   CCC5
DR   cancercelllines; CVCL_LM83
DR   DepMap; ACH-002647
DR   DSMZ; ACC-810
DR   DSMZCellDive; ACC-810
DR   Wikidata; Q54808767
RX   CelloPub=CLPUB00408;
RX   PubMed=35640676;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 60.5 hours (CelloPub=CLPUB00408); 2-3 days (DSMZ=ACC-810).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (CelloPub=CLPUB00408).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 20,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 13,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 11
//
RX   CelloPub=CLPUB00408;
RA   Zach S., Grun J., Bauer A.T., Pilarsky C., Grutzmann R., Weng H.-L.,
RA   Dooley S., Wilhelm T.J., Gaiser T., Ruckert F.;
RT   "CCC-5, a new primary cholangiocellular cell line.";
RL   Int. J. Clin. Exp. Pathol. 10:2451-2460(2017).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//